Company / R&D per Share
Teladoc Health, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.60
FY2025
5-year range
$1.60 / $2.14
FY2021-FY2025
Trend
-13.1%
vs FY2024
Sector context
#57 of 103
Health Care
What the data says
At $1.60, Teladoc Health, Inc.'s r&d per share ranks #57 of 103 in the Health Care sector. Declined from $2.14 to $1.60 over the past 2 years.
Based on SEC 10-K filings.
1.60 in FY2025 with a 5-year CAGR of -2.5%.
Declined from $2.14 to $1.60 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- -2.5%
- 10-Year CAGR
- -
Sector benchmark
#57 of 103 in Health CareTop 55% of 103This company $1.60 Sector average $2.13
▼
-24.8% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 13.1% year-over-year.
- Ranks #57 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.60 | -13.1% |
| FY2024 | $1.84 | -13.9% |
| FY2023 | $2.14 | +2.9% |
| FY2022 | $2.08 | +4.6% |
| FY2021 | $1.99 | +9.0% |
| FY2020 | $1.82 | +102.5% |
| FY2019 | $0.90 | +1.8% |
| FY2018 | $0.88 | +18.5% |
| FY2017 | $0.75 | +31.7% |
| FY2016 | $0.57 | -91.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026